Associations of Apolipoprotein E ε4 Genotype and Ball Heading With Verbal Memory in Amateur Soccer Players.
Journal
JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536
Informations de publication
Date de publication:
01 04 2020
01 04 2020
Historique:
pubmed:
28
1
2020
medline:
7
7
2020
entrez:
28
1
2020
Statut:
ppublish
Résumé
Emerging evidence suggests that long-term exposure to ball heading in soccer, the most popular sport in the world, confers risk for adverse cognitive outcomes. However, the extent to which the apolipoprotein E ε4 (APOE ε4) allele, a common risk factor for neurodegeneration, and ball heading are associated with cognition in soccer players remains unknown. To determine whether the APOE ε4 allele and 12-month ball heading exposure are associated with verbal memory in a cohort of adult amateur soccer players. A total of 379 amateur soccer players were enrolled in the longitudinal Einstein Soccer Study from November 11, 2013, through January 23, 2018. Selection criteria included participation in soccer for more than 5 years and for more than 6 months per year. Of the 379 individuals enrolled in the study, 355 were genotyped. Three players were excluded for reporting extreme levels of heading. Generalized estimating equation linear regression models were employed to combine data across visits for a cross-sectional analysis of the data. At each study visit every 3 to 6 months, players completed the HeadCount 12-Month Questionnaire, a validated, computer-based questionnaire to estimate 12-month heading exposure that was categorized as low (quartiles 1 and 2), moderate (quartile 3), and high (quartile 4). Verbal memory was assessed at each study visit using the International Shopping List Delayed Recall task from CogState. A total of 352 soccer players (256 men and 96 women; median age, 23 years [interquartile range, 21-28 years]) across a total of 1204 visits were analyzed. High levels of heading were associated with worse verbal memory performance (β = -0.59; 95% CI, -0.93 to -0.25; P = .001). There was no main association of APOE ε4 with verbal memory (β = 0.09; 95% CI, -0.24 to 0.42; P = .58). However, there was a significant association of APOE ε4 and heading with performance on the ISRL task (χ2 = 7.22; P = .03 for overall interaction). In APOE ε4-positive players, poorer verbal memory associated with high vs low heading exposure was 4.1-fold greater (APOE ε4 negative, β = -0.36; 95% CI, -0.75 to 0.03; APOE ε4 positive, β = -1.49; 95% CI, -2.05 to -0.93), and poorer verbal memory associated with high vs moderate heading exposure was 8.5-fold greater (APOE ε4 negative, β = -0.13; 95% CI, -0.54 to 0.29; APOE ε4 positive, β = -1.11, 95% CI, -1.70 to -0.53) compared with that in APOE ε4-negative players. This study suggests that the APOE ε4 allele is a risk factor for worse memory performance associated with higher heading exposure in the prior year, which highlights that assessing genetic risks may ultimately play a role in promoting safer soccer play.
Identifiants
pubmed: 31985774
pii: 2758831
doi: 10.1001/jamaneurol.2019.4828
pmc: PMC6990972
doi:
Substances chimiques
Apolipoprotein E4
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
419-426Subventions
Organisme : NIA NIH HHS
ID : K08 AG054727
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
J Neurotrauma. 2017 Jan 15;34(2):328-340
pubmed: 27029716
Ann Neurol. 2009 Jun;65(6):650-7
pubmed: 19557866
Sci Rep. 2017 Jul 27;7(1):6649
pubmed: 28751738
J Int Neuropsychol Soc. 2018 Feb;24(2):147-155
pubmed: 28829004
Science. 1993 Aug 13;261(5123):921-3
pubmed: 8346443
Science. 1994 May 6;264(5160):850-2
pubmed: 8171342
Lancet Neurol. 2011 Mar;10(3):241-52
pubmed: 21349439
Front Neurol. 2018 Apr 24;9:240
pubmed: 29740384
Neurosurgery. 2000 Sep;47(3):651-7; discussion 657-8
pubmed: 10981753
Neuron. 2012 Dec 6;76(5):871-85
pubmed: 23217737
Neurology. 2017 Feb 28;88(9):e74-e77
pubmed: 28242857
Neuropsychologia. 2015 Aug;75:411-9
pubmed: 26102189
J Neurosurg. 2013 Nov;119(5):1235-45
pubmed: 23971952
Neurology. 2017 Feb 28;88(9):901-908
pubmed: 28148633
Neurochem Res. 2007 Apr-May;32(4-5):905-15
pubmed: 17342413
Lancet Neurol. 2013 Feb;12(2):207-16
pubmed: 23332364
Sci Rep. 2017 Sep 12;7(1):11372
pubmed: 28900205
N Engl J Med. 2009 Jul 16;361(3):255-63
pubmed: 19605830
JAMA. 1997 Jul 9;278(2):136-40
pubmed: 9214529
J Sci Med Sport. 2018 Apr;21(4):363-367
pubmed: 28882435
J Clin Exp Neuropsychol. 2001 Dec;23(6):770-4
pubmed: 11910543
Arch Clin Neuropsychol. 2003 May;18(4):397-417
pubmed: 14591454
Curr Opin Neurobiol. 2011 Dec;21(6):920-8
pubmed: 21907569
Radiology. 2013 Sep;268(3):850-7
pubmed: 23757503
Mol Neurodegener. 2018 Apr 4;13(1):17
pubmed: 29618365
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2878-86
pubmed: 24183852
Arch Clin Neuropsychol. 2009 Mar;24(2):165-78
pubmed: 19395350